NDA Submission Of Epsolay Anticipated In First Half Of 2020
Sol Gel Technologies Ltd SLGL.O :
* SOL-GEL PROVIDES PRODUCT PIPELINE UPDATES AND ANTICIPATED
MILESTONES FOR 2020
* SOL GEL TECHNOLOGIES LTD - NDA SUBMISSION OF EPSOLAY
ANTICIPATED
IN FIRST HALF OF 2020
* SOL GEL TECHNOLOGIES - REMAINS ON TRACK TO SUBMIT NDA FOR
EPSOLAY FOR TREATMENT OF PAPULOPUSTULAR ROSACEA IN FIRST HALF OF
2020
* SOL GEL TECHNOLOGIES - REMAINS ON TRACK TO SUBMIT NDA FOR
TWYNEO
FOR ACNE VULGARIS IN SECOND HALF OF 2020
Source text for Eikon: ID:nGNXcdMSty
Further company coverage: SLGL.O
Recent news on SOL-GEL TECHNOLOGIES
See all newsIsraeli dermatology firm Sol-Gel's Q2 revenue drops sharply on prior-year IP sale
SOL-GEL TECHNOLOGIES LTD. expected to post a loss of $2.57 a share - Earnings Preview
Sol-Gel Q1 revenue falls sharply on milestone payment impact
Brief: Sol-Gel Technologies Ltd. Q1 Revenue USD 100 Thousand
Brief: Sol-Gel Technologies Ltd. Announces Pricing Of Oversubscribed Underwritten Offering